CompletedNot Applicable

The Effects of PFMT and MPE in Elderly Women With SUI.

Turkey (Türkiye)30 participantsStarted 2020-07-20

Plain-language summary

The aim of the study was to compare the effects of PFMT and MPE on SUI frequency and explosure from symptoms, PFM activation response and strength of lumbar stabilizing muscle in elderly women with SUI.

Who can participate

Age range

65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. being volunteer to participate in a study;
. being a woman over the age of 65;
. having the diagnosis of SUI;
. participants who scored at least 24 on the Mini Mental State Exam (MMSE).

Exclusion criteria

. having a neurological disease;
. having PFM which cannot contract;
. having a urinary tract infection;
. having the stage two or higher pelvic organ prolapse; and
. participants who received a SUI treatment in the recent year.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

SUI frequency change - Incontinence Severity Index (ISI)

Timeframe: SUI frequency was assessed by Incontinence Severity Index (ISI) at before and after 12 weeks of treatment

SUI frequency and explosure from symptoms change - Urogenital Distress Inventory-Short Form (UDI-6)

Timeframe: SUI frequency and explosure from symptoms was assessed by Urogenital Distress Inventory-Short Form (UDI-6) at before and after 12 weeks of treatment

SUI frequency and explosure from symptoms change - Incontinence Impact Questionnaire-Short Form (IIQ-7)

Timeframe: SUI frequency and explosure from symptoms was assessed by Incontinence Impact Questionnaire-Short Form (IIQ-7) at before and after 12 weeks of treatment

PFM activation change - MyoPlus4Puro-EMG device

Timeframe: PFM activation was assessed by MyoPlus4Puro-EMG device at before and after 12 weeks of treatment

Strength of lumbar stabilizing muscle change - Stabilizer Pressure Biofeedback

Timeframe: Strength of lumbar stabilizing muscle was assessed by stabilizer at before and after 12 weeks of treatment

Trial details

NCT IDNCT05390008

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-20

View on ClinicalTrials.gov More Stress Urinary Incontinence trials